These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29683114)

  • 1. Trajectories of Cognitive Function and Associated Phenotypic and Genotypic Factors in Breast Cancer.
    Bender CM; Merriman JD; Sereika SM; Gentry AL; Casillo FE; Koleck TA; Rosenzweig MQ; Brufsky AM; McAuliffe P; Zhu Y; Conley YP
    Oncol Nurs Forum; 2018 May; 45(3):308-326. PubMed ID: 29683114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer.
    Merriman JD; Sereika SM; Brufsky AM; McAuliffe PF; McGuire KP; Myers JS; Phillips ML; Ryan CM; Gentry AL; Jones LD; Bender CM
    Psychooncology; 2017 Jan; 26(1):44-52. PubMed ID: 26486371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.
    Bender CM; Sereika SM; Brufsky AM; Ryan CM; Vogel VG; Rastogi P; Cohen SM; Casillo FE; Berga SL
    Menopause; 2007; 14(6):995-8. PubMed ID: 17898668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does lifetime exposure to hormones predict pretreatment cognitive function in women before adjuvant therapy for breast cancer?
    Bender CM; Sereika SM; Ryan CM; Brufsky AM; Puhalla S; Berga SL
    Menopause; 2013 Sep; 20(9):922-9. PubMed ID: 23481123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploratory Study of Associations Between DNA Repair and Oxidative Stress Gene Polymorphisms and Cognitive Problems Reported by Postmenopausal Women With and Without Breast Cancer.
    Merriman JD; Sereika SM; Conley YP; Koleck TA; Zhu Y; Phillips ML; Bertocci MA; Brufsky AM; Bender CM
    Biol Res Nurs; 2019 Jan; 21(1):50-60. PubMed ID: 30213196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer.
    Koleck TA; Bender CM; Sereika SM; Ahrendt G; Jankowitz RC; McGuire KP; Ryan CM; Conley YP
    Oncol Nurs Forum; 2014 Nov; 41(6):E313-25. PubMed ID: 25355028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study.
    Tager FA; McKinley PS; Schnabel FR; El-Tamer M; Cheung YK; Fang Y; Golden CR; Frosch ME; Habif U; Mulligan MM; Chen IS; Hershman DL
    Breast Cancer Res Treat; 2010 Aug; 123(1):25-34. PubMed ID: 19894112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genes Involved in the HPA Axis and the Symptom Cluster of Fatigue, Depressive Symptoms, and Anxiety in Women With Breast Cancer During 18 Months of Adjuvant Therapy.
    Li H; Marsland AL; Conley YP; Sereika SM; Bender CM
    Biol Res Nurs; 2020 Apr; 22(2):277-286. PubMed ID: 31908177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research.
    Rugo HS; Ahles T
    Semin Oncol; 2003 Dec; 30(6):749-62. PubMed ID: 14663776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective.
    Hurria A; Goldfarb S; Rosen C; Holland J; Zuckerman E; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Robson M; Currie VE; Theodoulou M; Norton L; Hudis C
    Breast Cancer Res Treat; 2006 Aug; 98(3):343-8. PubMed ID: 16541322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer.
    Lange M; Heutte N; Noal S; Rigal O; Kurtz JE; Lévy C; Allouache D; Rieux C; Lefel J; Clarisse B; Leconte A; Veyret C; Barthélémy P; Longato N; Tron L; Castel H; Eustache F; Giffard B; Joly F
    Oncologist; 2019 Jan; 24(1):62-68. PubMed ID: 29934409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
    Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR
    J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors.
    Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
    Crit Rev Oncol Hematol; 2010 Nov; 76(2):133-41. PubMed ID: 20036141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focus on anastrozole and breast cancer.
    Mokbel K
    Curr Med Res Opin; 2003; 19(8):683-8. PubMed ID: 14687437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant use of aromatase inhibitors in postmenopausal women with breast cancer.
    Michaud LB
    Am J Health Syst Pharm; 2005 Feb; 62(3):266-73. PubMed ID: 15719584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study.
    Fischer B
    Neurocase; 2019; 25(3-4):138-144. PubMed ID: 31237172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced prospective memory impairment in patients with breast cancer.
    Cheng H; Yang Z; Dong B; Chen C; Zhang M; Huang Z; Chen Z; Wang K
    Psychooncology; 2013 Oct; 22(10):2391-5. PubMed ID: 23674402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors.
    Breckenridge LM; Bruns GL; Todd BL; Feuerstein M
    Psychooncology; 2012 Jan; 21(1):43-53. PubMed ID: 20967847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
    Hurria A; Rosen C; Hudis C; Zuckerman E; Panageas KS; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Hurria A; Holland J
    J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment associated with adjuvant therapy in breast cancer.
    Bender CM; Sereika SM; Berga SL; Vogel VG; Brufsky AM; Paraska KK; Ryan CM
    Psychooncology; 2006 May; 15(5):422-30. PubMed ID: 16097037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.